Inventory decreased 41.5%
Inventory changed -41.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed -41.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed -82.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed +79.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed +26.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed -12.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating margin changed +116 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed -5.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed +3.2% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.